Corcept Therapeutics's total assets for Q4 2025 were $836.65M, an increase of 1.58% from the previous quarter. CORT total liabilities were $188.85M for the fiscal quarter, a -1.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.